Package 70518-2266-2

{"route": ["ORAL"], "spl_id": "49f005c0-661d-691e-e063-6294a90a0994", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["740bbed7-b2dd-4ad9-99e0-03a9f1d61e3f"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2266-0)", "package_ndc": "70518-2266-0", "marketing_start_date": "20190815"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2266-1)", "package_ndc": "70518-2266-1", "marketing_start_date": "20210526"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2266-2)", "package_ndc": "70518-2266-2", "marketing_start_date": "20210706"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "70518-2266_49f005c0-661d-691e-e063-6294a90a0994", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-2266", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20190815", "listing_expiration_date": "20271231"}